BioCentury
ARTICLE | Clinical News

Aquila misses mastitis end point

May 3, 2000 7:00 AM UTC

AQLA said preliminary results of a licensing trial of Quilvax-M to manage S. aureus mastitis in dairy cows failed to hit its primary end point of reducing average somatic cell counts. A control group ...